Affordable Access

deepdyve-link
Publisher Website

Contemporary Context of Drug-Eluting Stents in Brazil: A Cost Utility Study.

Authors
  • Stella, Steffan Frosi1, 2
  • Gehling Bertoldi, Eduardo1, 2, 3
  • Polanczyk, Carísi Anne1, 2, 4, 5
  • 1 Graduate Program in Cardiology and Cardiovascular Sciences, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil (SFS, EGB, CAP) , (Brazil)
  • 2 National Institute of Science and Technology for Health Technology Assessment (IATS), CNPq, Brazil (SFS, EGB, CAP) , (Brazil)
  • 3 Department of Internal Medicine, School of Medicine, Universidade Federal de Pelotas, Pelotas, Brazil (EGB) , (Brazil)
  • 4 Department of Internal Medicine, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil (CAP) , (Brazil)
  • 5 Cardiology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (CAP) , (Brazil)
Type
Published Article
Journal
Medical decision making : an international journal of the Society for Medical Decision Making
Publication Date
Nov 01, 2016
Volume
36
Issue
8
Pages
1034–1042
Identifiers
DOI: 10.1177/0272989X16636054
PMID: 26964876
Source
Medline
Keywords
License
Unknown

Abstract

DES is not a good value for money in SUS perspective, despite its benefit in reducing target vessel revascularization. Since the cost-effectiveness of DES is mainly driven by the stents' cost difference, they should cost less than twice the BMS price to become a cost-effective alternative.

Report this publication

Statistics

Seen <100 times